107 related articles for article (PubMed ID: 4662053)
1. [Prevention of vascular disorders during administration of estroprogestative contraceptives with a medication containing extracts of Ginkgo biloba].
Grasset J; Gauthier R
Phlebologie; 1972; 25(3):269-72. PubMed ID: 4662053
[No Abstract] [Full Text] [Related]
2. [Venous complications caused by estroprogestative treatment at the Strasbourg University Maternity Hospital].
Muller P; Dellenbach P
Phlebologie; 1972; 25(3):256-7. PubMed ID: 4662050
[No Abstract] [Full Text] [Related]
3. [Vascular and gynecological consequences of estroprogestatives].
Chabrier J; Choukroun J
Phlebologie; 1972; 25(3):251-4. PubMed ID: 4662049
[No Abstract] [Full Text] [Related]
4. Clinical evaluation of side effects of current oral contraceptives.
Nelson JH
J Reprod Med; 1971 Feb; 6(2):50-5. PubMed ID: 4255975
[No Abstract] [Full Text] [Related]
5. [Synthetic estroprogestatives and phlebology. Introduction].
Muller P
Phlebologie; 1972; 25(3):223-6. PubMed ID: 4662045
[TBL] [Abstract][Full Text] [Related]
6. [The outcome of an enquiry into synthetic estroprogestatives and their effects on venous circulation].
Wallois P; Abeille JP; Griton P
Phlebologie; 1972; 25(3):227-35. PubMed ID: 4662046
[No Abstract] [Full Text] [Related]
7. [Synthetic progestogens and phlebopathies].
Degrassi R
Minerva Med; 1971 Feb; 62(16):743-4. PubMed ID: 5549395
[No Abstract] [Full Text] [Related]
8. [Venous pathology with estrogens-progestagens].
Vin F; Allaert FA; Levardon M
Phlebologie; 1989; 42(3):473-9; discussion 479-80. PubMed ID: 2626469
[No Abstract] [Full Text] [Related]
9. [Risk of thrombophlebitis during hormonal contraception].
Ludwig H
Ther Umsch; 1971 Aug; 28(8):516-21. PubMed ID: 5119110
[No Abstract] [Full Text] [Related]
10. [Estrogens and vascular risk].
Corvol P; Ménard J; Milliez P
Rev Prat; 1979 Apr; 29(21):1755-8, 1761-5. PubMed ID: 472623
[No Abstract] [Full Text] [Related]
11. Mucha-Habermann disease following estrogen-progesterone therapy.
Hollander A; Grots IA
Arch Dermatol; 1973 Mar; 107(3):465. PubMed ID: 4692137
[No Abstract] [Full Text] [Related]
12. [Review of side effects of oral contraceptives].
Janssens J
Nature; 1970 Jul; 227(5256):1418-22. PubMed ID: 5448324
[No Abstract] [Full Text] [Related]
13. [Oral contraceptives: update].
Fugère P
Union Med Can; 1983 Feb; 112(2):109-12. PubMed ID: 6845551
[No Abstract] [Full Text] [Related]
14. [Arterial hypertension during treatment with estro-progestative agents].
Dumont M; Pellissier B; Laforet J; Dick D
J Med Lyon; 1971 Mar; 52(204):381-3. PubMed ID: 5135329
[No Abstract] [Full Text] [Related]
15. [Choice of ovulation inhibitors].
Mall-Haefeli M
Ther Umsch; 1970 Oct; 27(10):652-9. PubMed ID: 5512723
[No Abstract] [Full Text] [Related]
16. [Trends in drug-hormone contraception].
Kuemmerle HP
Int Z Klin Pharmakol Ther Toxikol; 1968; 1(6):465-6. PubMed ID: 5718773
[No Abstract] [Full Text] [Related]
17. Changing oral contraceptives.
Br Med J; 1969 Dec; 4(5686):789-91. PubMed ID: 5359946
[No Abstract] [Full Text] [Related]
18. [Contraceptives. Side effects and risks].
García-Conti F
Rev Colomb Obstet Ginecol; 1971; 22(6):393-407. PubMed ID: 4947668
[No Abstract] [Full Text] [Related]
19. Relationship of estrogens and oral contraceptives to endometrial cancer in animals and women.
Drill VA
J Reprod Med; 1980 Jan; 24(1):5-13. PubMed ID: 6987399
[TBL] [Abstract][Full Text] [Related]
20. [Clinical results in therapy of peripheral vascular diseases with ginkgo-biloba].
Bartolo M
Minerva Med; 1973 Nov; 64(79 Suppl):4187-93. PubMed ID: 4592295
[No Abstract] [Full Text] [Related]
[Next] [New Search]
